CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 550 enrolled
Drug / intervention
poliglecaprone 25 suture +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02459093
NCT02459093Phase 4Completed

Comparison of Subcuticular Suture Type in Post-Cesarean Wound Complications

Montefiore Medical Center·interventional·Posted Jun 1, 2015·Updated Jun 1, 2018

In Brief

A Phase 4 clinical trial evaluating poliglecaprone 25 suture and polyglactin 910 suture for Complications; Cesarean Section and Surgical Wound Infection. Completed, enrolled 550 participants across 2 sites.

Detailed Summary

A comparison of the type of suture used for cesarean skin incision approximation and the subsequent rate of wound complications has not been widely studied. Investigators seek to compare poliglecaprone 25 and polyglactin 910 suture used in a subcuticular skin closure in Pfannenstiel incisions during cesarean birth and determine the subsequent wound complication rates (SSI, hematoma, seroma, wound separation).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 1, 2015
Enrollment StartMay 1, 2015
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.1 years ago

Interventions

poliglecaprone 25 suturedevice

cesarean delivery incision closure with poliglecaprone 25 suture

polyglactin 910 suturedevice

cesarean delivery incision closure with polyglactin 910 suture